These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of muscle relaxants on the motor endplate of diabetic and glucocorticoid pretreated rats. Minker E; Kac P; Koltai M Acta Physiol Hung; 1986; 67(2):257-66. PubMed ID: 3017049 [TBL] [Abstract][Full Text] [Related]
25. [Participation of natural imidazole-containing dipeptides in the biosynthesis and reception of acetylcholine]. Severin SE Usp Sovrem Biol; 1967; 64(2):181-96. PubMed ID: 4321653 [No Abstract] [Full Text] [Related]
26. Inhibition and facilitation in parasympathetic ganglia of the urinary bladder. de Groat WC; Booth AM Fed Proc; 1980 Oct; 39(12):2990-6. PubMed ID: 6106562 [TBL] [Abstract][Full Text] [Related]
27. The autonomic margins of safety of metocurine and d-tubocurarine in the cat. Savarese JJ Anesthesiology; 1979 Jan; 50(1):40-6. PubMed ID: 83803 [TBL] [Abstract][Full Text] [Related]
28. [Muscle relaxants]. Ota Y Masui; 1996 Dec; 45 Suppl():S212-9. PubMed ID: 9044940 [No Abstract] [Full Text] [Related]
29. Influence of lanthanum on transmitter release at the neuromuscular junction. DeBassio WA; Schnitzler RM; Parsons RL J Neurobiol; 1971; 2(3):263-78. PubMed ID: 4400110 [No Abstract] [Full Text] [Related]
30. [The mechanism of blockade and recovery of neuromuscular transmission under the influence of armin in experiments on cats]. Danilov AF; Ivanov IuIa Farmakol Toksikol; 1972; 35(5):571-5. PubMed ID: 4346937 [No Abstract] [Full Text] [Related]
31. Options on the use of muscle relaxants in clinical anaesthesia. Vilardi V Minerva Anestesiol; 2001 Mar; 67(3):91-5; discussion 95-6. PubMed ID: 11337640 [No Abstract] [Full Text] [Related]
32. Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade. Booij LH Pharm World Sci; 1997 Feb; 19(1):1-12. PubMed ID: 9089749 [TBL] [Abstract][Full Text] [Related]
33. Applied pharmacology of common neuromuscular blocking agents in critical care. Prielipp RC; Coursin DB New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711]. Laubie M; Le Douarec JC Arzneimittelforschung; 1969 Nov; 19(11):1820-6. PubMed ID: 4391788 [No Abstract] [Full Text] [Related]
35. Muscle relaxants in infants and children. Cook DR Anesth Analg; 1981 May; 60(5):335-43. PubMed ID: 6261612 [TBL] [Abstract][Full Text] [Related]
36. The effects of inorganic lead on cholinergic transmission. Goldberg AM Prog Brain Res; 1979; 49():465-70. PubMed ID: 229519 [No Abstract] [Full Text] [Related]
37. [The duration of neuromuscular blockade with non-depolarizing muscle relaxants in anephric rats (author's transl)]. Amaki Y; Satake T Masui; 1981 Jan; 30(1):20-6. PubMed ID: 7218507 [No Abstract] [Full Text] [Related]
38. [Functional organization of the autonomic nervous system]. Samonina GE; Sokolova NA; Kopylova GN Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):6-20. PubMed ID: 6133565 [TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Brown MR; Fisher LA Fed Proc; 1985 Jan; 44(1 Pt 2):243-8. PubMed ID: 2981744 [TBL] [Abstract][Full Text] [Related]
40. The analysis of cardiovascular action of 10-(3-dimethylaminopropyl)-7-chlorobenzo-(b)-(1,8)-naphthyridone-5 monohydrochloride (IF-C-45) with antidepressant properties. Filczewski M; Oledka K; Ernest K; Paszek T Pol J Pharmacol Pharm; 1975; 27(2):121-37. PubMed ID: 1153349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]